We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.52%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$5.65B
AUM Growth
+$471M
(+9.1%)
Cap. Flow
+$283M
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
17.56%
Holding
1,507
New
476
Increased
192
Reduced
202
Closed
448
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$14.4M |
| 2 |
argenx
ARGX
|
+$13.4M |
| 3 |
Compañía de Minas Buenaventura
BVN
|
+$13.1M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$11.3M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KraneShares CSI China Internet ETF
KWEB
|
+$16.7M |
| 2 |
Sabre
SABR
|
+$12.5M |
| 3 |
UBS Group
UBS
|
+$10.2M |
| 4 |
Walt Disney
DIS
|
+$9.97M |
| 5 |
CBL
CBL Properties
CBL
|
+$7.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.56% |
| 2 | Technology | 1.89% |
| 3 | Consumer Discretionary | 0.9% |
| 4 | Communication Services | 0.87% |
| 5 | Industrials | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
MasTec
MTZ
$21B
| $2.24M | 0.04% |
+19,000
| New | +$1.86M |
|
477
CALL
KE Holdings
BEKE
$19.1B
| $2.23M | 0.04% |
+150,000
| New | +$2.45M |
|
478
CALL
Viridian Therapeutics
VRDN
$2.13B
| $2.19M | 0.04% |
92,200
+42,200
| +84% | +$1.08M |
|
479
CALL
AstraZeneca
AZN
$245B
| $2.15M | 0.04% |
15,000
-39,250
| -72% | -$5.78M |
|
480
American Tower
AMT
$80.6B
| $2.13M | 0.04% |
+11,000
| New | +$2.15M |
|
481
CALL
Bloom Energy
BE
$64.3B
| $2.13M | 0.04% |
+130,400
| New | +$2.11M |
|
|
BERY
482
PUT
DELISTED
Berry Global Group, Inc.
BERY
| $2.12M | 0.04% |
+35,828
| New | +$1.96M |
|
483
Insmed
INSM
$21.3B
| $2.11M | 0.04% |
100,000
+86,700
| +652% | +$1.64M |
|
484
CALL
Evolv Technologies
EVLV
$1.02B
| $2.1M | 0.04% |
350,000
+225,000
| +180% | +$1.06M |
|
|
IMGN
485
CALL
DELISTED
Immunogen Inc
IMGN
| $2.08M | 0.04% |
+110,000
| New | +$1.3M |
|
486
PUT
Legend Biotech
LEGN
$3.68B
| $2.07M | 0.04% |
+30,000
| New | +$1.96M |
|
487
PUT
Lucid Motors
LCID
$3B
| $2.06M | 0.04% |
29,850
+13,500
| +83% | +$963K |
|
488
PUT
Baxter International
BAX
$14.5B
| $2.05M | 0.04% |
45,000
-10,000
| -18% | -$435K |
|
489
PUT
CAVA Group
CAVA
$7.51B
| $2.05M | 0.04% |
+50,000
| New | +$2.06M |
|
|
MAXN
490
CALL
DELISTED
Maxeon Solar Technologies
MAXN
| $2.04M | 0.04% |
725
+200
| +38% | +$572K |
|
491
PUT
Caesars Entertainment
CZR
$6.06B
| $2.04M | 0.04% |
40,000
| – | – |
|
492
CALL
SentinelOne
S
$6.87B
| $2.04M | 0.04% |
135,000
-215,000
| -61% | -$3.64M |
|
493
BlackLine
BL
$1.92B
| $2.03M | 0.04% |
+37,800
| New | +$2.1M |
|
494
Alphabet (Google) Class C
GOOG
$4.56T
| $2.01M | 0.04% |
16,641
-51,759
| -76% | -$5.99M |
|
495
PUT
Alibaba
BABA
$305B
| $1.99M | 0.04% |
+23,900
| New | +$2.09M |
|
496
CALL
Axsome Therapeutics
AXSM
$10.9B
| $1.98M | 0.04% |
27,500
-2,500
| -8% | -$184K |
|
|
497
PUT
Axsome Therapeutics
AXSM
$10.9B
| $1.98M | 0.04% |
27,500
-2,500
| -8% | -$184K |
|
498
Myriad Genetics
MYGN
$285M
| $1.97M | 0.03% |
+85,017
| New | +$1.86M |
|
|
SPLK
499
CALL
DELISTED
Splunk Inc
SPLK
| $1.95M | 0.03% |
18,400
| – | – |
|
500
PUT
Option Care Health
OPCH
$3.55B
| $1.95M | 0.03% |
+60,000
| New | +$1.81M |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2023 Portfolio in Review
As of Q2 2023, Caption Management held 1,507 positions worth $5.65B, up 9.1% from $5.18B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Caption Management deployed $283M of net new capital in Q2 2023, opening 476 new positions and adding to 192 existing holdings. Its largest new stake was Lockheed Martin: 31,000 shares worth $14.3M.
By sector, the portfolio is most concentrated in Healthcare at 2.6% of assets, up from 2% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Sabre, an estimated $12.5M trimmed.
- Caption Management's largest Q2 2023 buy was Lockheed Martin: 31,000 shares worth $14.3M.
- Caption Management added most to State Street SPDR S&P Biotech ETF in Q2 2023, an estimated $11M increase.
- Caption Management's biggest Q2 2023 reduction was Sabre, cutting an estimated $12.5M.
- Caption Management fully exited KraneShares CSI China Internet ETF in Q2 2023, selling an estimated $16.7M.
- Caption Management's ten largest holdings make up 18% of its $5.65B portfolio in Q2 2023.
- Caption Management opened 476 new positions and closed 448 in Q2 2023.
- Caption Management's portfolio value rose 9.1% quarter-over-quarter to $5.65B.
Based on Caption Management's 13F filing for Q2 2023, filed 14 Aug 2023.